Reassessment of pelvic lymph node debulking in advanced cervical cancer [1]

Gynecologic Oncology

Volumn 92, Issue 3, 2004, Pages 1014-1015

  Tammela, Jonathan ^a   Bundy, Brian ^a   Odunsi, Kunle ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

ADVANCED CANCER; CALCULATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; DISEASE SEVERITY; FEASIBILITY STUDY; FOLLOW UP; HUMAN; INCIDENCE; LETTER; PELVIS LYMPH NODE; PRIORITY JOURNAL; RADIATION DOSE; STANDARD; SURVIVAL RATE; TUMOR VOLUME; UTERINE CERVIX CANCER;

EID: 1342321822     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2003.11.030     Document Type: Letter

References (3)

1. Kupets R., Thomas G., Covens A. Is there a role for pelvic lymph node debulking in advanced cervical cancer? Gynecol. Oncol. 87:2002;163-170.
2. Petterson F., Coppleson M., Creasman W. Twentieth annual report on the results of treatment in gynecologic cancer. 1988;International Federation of Gynecology and Obstetrics, Stockholm.
3. Cosin J.A., Fowler J.M., Chen M.D., Paley P.J., Carson L.F., Twiggs L.B. Pretreatment surgical staging of patients with cervical carcinoma: the case for lymph node debulking. Cancer. 82(11):1998;2241-2249.